- 积分
- 116
- 威望
- 116
- 包包
- 790
|
1 l! Q7 a) {. _6 k
% l- x, a A% i: u. P: mReview' u( ~, f& e0 C& n0 S/ J
Oncogene (2011) 30, 3477–3488; doi:10.1038/onc.2011.160; published online 16 May 20117 Q! ]: B# {7 D! m) q" E. s
) N/ P: z, U+ A, `- i$ F
Raf kinases in cancer–roles and therapeutic opportunities( }& L6 Z! ^2 U6 T/ Y @
G Maurer1, B Tarkowski1 and M Baccarini1
1 {$ f2 x1 l" `+ h+ u) ?& S; ^: @8 ~1 K# m
http://www.nature.com/onc/journal/v30/n32/pdf/onc2011160a.pdf/ H% N7 M8 A; Z; ^
0 ?1 E$ w! \! O5 s+ O2. o4 t1 k$ E( a
+ T L! o; @: [: G8 ~+ QMicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways" ?+ g: z8 s+ S5 s. J
C Oneyama, J Ikeda, D Okuzaki, K Suzuki, T Kanou, Y Shintani, E Morii, M Okumura, K Aozasa and M Okada
2 [2 c6 o. [- e7 m7 k* m
3 X6 `8 M! p# Ehttp://www.nature.com/onc/journal/v30/n32/pdf/onc201163a.pdf |
|